EED226-COOH

Target: This ligand targets embryonic ectoderm development protein EED within the PRC2 complex in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for embryonic ectoderm development protein EED within the PRC2 complex. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings embryonic ectoderm development protein EED within the PRC2 complex into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• EED226-Based E3 Recruitment: EED226-COOH is designed to engage the EED component of the Polycomb Repressive Complex 2 (PRC2), enabling PROTAC-mediated recruitment of this E3 interface. In targeted protein degradation studies, it can be conjugated to appropriate ligands to drive ubiquitination and proteasomal removal of PRC2-associated or PRC2-dependent proteins.

• PRC2-Dependent Degradation Studies: By leveraging EED226-COOH’s PRC2-binding mode, PROTAC constructs can be used to interrogate how disrupting PRC2 activity reshapes chromatin states. This application supports systematic degradation of PRC2-linked targets, allowing mechanistic evaluation of downstream transcriptional programs and epigenetic maintenance.

• Chromatin Signaling Mechanism Probing: EED226-COOH-based PROTACs can be applied to map causal relationships between PRC2 engagement and degradation-driven phenotypes. Researchers can compare degradation kinetics and pathway dependence across target proteins, clarifying how EED/PRC2 recruitment influences signaling cascades and cellular stress responses.

• Targeted Epigenetic Regulation Tools: EED226-COOH can serve as a modular E3-recruiting element in PROTAC design to build tools for selective depletion of epigenetic regulators. Such constructs facilitate controlled perturbation of histone modification networks, supporting studies of how specific degraded factors alter chromatin accessibility and gene expression dynamics.

EED226-COOH is a EED/PRC2 target ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of EED226-COOH is characterized by carboxylic acid or carboxylate handle; primary or secondary amine/basic nitrogen centers; heteroaromatic protein-recognition scaffold. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The acid handle supports amide coupling with amino-PEG, alkyl-diamine, piperazine, or aminoalkyl E3-ligase ligands. For PROTAC construction, the POI ligand can be paired with CRBN ligands such as thalidomide, pomalidomide, or lenalidomide analogues, VHL ligands such as VH032 derivatives, or less common IAP/MDM2/cIAP-recruiting ligands, with alkyl, PEG, piperazine, triazole, or amide linkers screened for ternary-complex formation. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.